| Arnecia Moody, | |
|
1706 Palmetto Dr, Mitchellville, MD 20721-3718 | |
| (301) 883-9116 | |
| Not Available |
| Full Name | Arnecia Moody |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1706 Palmetto Dr, Mitchellville, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306251939 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 17865 (Maryland) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
CombiMatrix Corporation announced today that it is implementing a restructuring plan to significantly reduce operating costs, increase the focus on the Company's diagnostic services business and transition senior management. After the restructuring, CombiMatrix will be focused on its diagnostics services business, including increasing utilization of its existing tests, expanding the test menu, increasing the number of customers and partners, and improving reimbursement for its testing services.
University of Alaska Fairbanks scientists have identified what they think is the ancestral trait that allowed for the evolution of air breathing in vertebrates. They will present their research at the 42nd annual meeting of the Society for Neuroscience Oct. 17 in New Orleans.
Humans and chimps share most of their genes, yet they differ dramatically in many ways - their walk, the sizes of their brains and their capacities for speech and language, for example.
New vaccines and drug treatments are urgently needed for bacterial meningitis, a devastating disease which kills or maims around a fifth of people who contract it, according to medical experts writing in a new Series on bacterial meningitis, published in The Lancet.
The US Food and Drug Administration (FDA) approved Tekamlo™ (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna® (aliskiren), with the widely used calcium channel blocker amlodipine. Tekamlo is approved as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals, and as replacement therapy for patients whose blood pressure is not adequately controlled with either aliskiren or amlodipine alone.
› Verified 8 days ago
| Entity Name | Interdynamics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952570343 PECOS PAC ID: 2860670213 Enrollment ID: O20110707000233 |
News Archive
CombiMatrix Corporation announced today that it is implementing a restructuring plan to significantly reduce operating costs, increase the focus on the Company's diagnostic services business and transition senior management. After the restructuring, CombiMatrix will be focused on its diagnostics services business, including increasing utilization of its existing tests, expanding the test menu, increasing the number of customers and partners, and improving reimbursement for its testing services.
University of Alaska Fairbanks scientists have identified what they think is the ancestral trait that allowed for the evolution of air breathing in vertebrates. They will present their research at the 42nd annual meeting of the Society for Neuroscience Oct. 17 in New Orleans.
Humans and chimps share most of their genes, yet they differ dramatically in many ways - their walk, the sizes of their brains and their capacities for speech and language, for example.
New vaccines and drug treatments are urgently needed for bacterial meningitis, a devastating disease which kills or maims around a fifth of people who contract it, according to medical experts writing in a new Series on bacterial meningitis, published in The Lancet.
The US Food and Drug Administration (FDA) approved Tekamlo™ (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna® (aliskiren), with the widely used calcium channel blocker amlodipine. Tekamlo is approved as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals, and as replacement therapy for patients whose blood pressure is not adequately controlled with either aliskiren or amlodipine alone.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arnecia Moody, 1706 Palmetto Dr, Mitchellville, MD 20721-3718 Ph: (301) 883-9116 | Arnecia Moody, 1706 Palmetto Dr, Mitchellville, MD 20721-3718 Ph: (301) 883-9116 |
News Archive
CombiMatrix Corporation announced today that it is implementing a restructuring plan to significantly reduce operating costs, increase the focus on the Company's diagnostic services business and transition senior management. After the restructuring, CombiMatrix will be focused on its diagnostics services business, including increasing utilization of its existing tests, expanding the test menu, increasing the number of customers and partners, and improving reimbursement for its testing services.
University of Alaska Fairbanks scientists have identified what they think is the ancestral trait that allowed for the evolution of air breathing in vertebrates. They will present their research at the 42nd annual meeting of the Society for Neuroscience Oct. 17 in New Orleans.
Humans and chimps share most of their genes, yet they differ dramatically in many ways - their walk, the sizes of their brains and their capacities for speech and language, for example.
New vaccines and drug treatments are urgently needed for bacterial meningitis, a devastating disease which kills or maims around a fifth of people who contract it, according to medical experts writing in a new Series on bacterial meningitis, published in The Lancet.
The US Food and Drug Administration (FDA) approved Tekamlo™ (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna® (aliskiren), with the widely used calcium channel blocker amlodipine. Tekamlo is approved as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals, and as replacement therapy for patients whose blood pressure is not adequately controlled with either aliskiren or amlodipine alone.
› Verified 8 days ago
Audra N Gillis, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1701 Enterprise Rd, Mitchellville, MD 20721 Phone: 301-442-1990 Fax: 301-627-1806 | |
Ms. Lesley Ann Ellis, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 12138 Central Avenue, #662, Mitchellville, MD 20721 Phone: 301-336-3242 |